Skip to content

AZN

AstraZeneca PLC

Cash flow statement

Cash flow statement
Line, in USD20252024202320222021202020192018201720162015
Operating cash flow14.6B11.9B10.3B9.8B6.0B4.8B3.0B2.6B3.6B4.1B3.3B
2.81B1.92B1.36B1.09B1.09B0.96B0.98B1.04B1.33B1.45B1.33B
Free cash flow11.8B9.9B9.0B8.7B4.9B3.8B2.0B1.6B2.3B2.7B2.0B
Depreciation and amortization———5.48B6.53B3.15B3.76B3.75B3.04B2.36B2.85B
Stock-based compensation719M660M579M619M615M277M259M219M220M241M211M
Buybacks521M81M——149M——————
Dividends paid4.97B4.63B4.48B4.36B3.86B3.57B3.59B3.48B3.52B3.56B3.49B
Dividends per share3.135.945.805.805.605.60—————
Free cash flow margin20.0%18.4%19.6%19.7%13.0%14.4%8.2%7.1%10.0%11.7%8.1%